These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1732009

  • 21. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937.
    Peiretti F, Fossat C, Anfosso F, Alessi MC, Henry M, Juhan-Vague I, Nalbone G.
    Blood; 1996 Jan 01; 87(1):162-73. PubMed ID: 8547638
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
    Baker MS, Bleakley P, Woodrow GC, Doe WF.
    Cancer Res; 1990 Aug 01; 50(15):4676-84. PubMed ID: 2114945
    [Abstract] [Full Text] [Related]

  • 23. Production of plasminogen activator and plasminogen activator inhibitor by bovine lymphatic endothelial cells: modulation by TNF-alpha.
    Laschinger CA, Johnston MG, Hay JB, Wasi S.
    Thromb Res; 1990 Aug 01; 59(3):567-79. PubMed ID: 2237828
    [Abstract] [Full Text] [Related]

  • 24. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G, Bjornsson TD, Vlodavsky I.
    J Cell Physiol; 1993 Mar 01; 154(3):456-65. PubMed ID: 8436596
    [Abstract] [Full Text] [Related]

  • 25. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER, Snegovskikh V, Schatz F, Foyouzi N, Rahman M, Buchwalder L, Lee HJ, Funai EF, Buhimschi CS, Buhimschi IA, Lockwood CJ.
    Am J Obstet Gynecol; 2007 Apr 01; 196(4):382.e1-8. PubMed ID: 17403427
    [Abstract] [Full Text] [Related]

  • 26. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW.
    Kidney Int; 1995 Apr 01; 47(4):1039-47. PubMed ID: 7540230
    [Abstract] [Full Text] [Related]

  • 27. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 01; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 28. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
    Basire A, Sabatier F, Ravet S, Lamy E, Mialhe A, Zabouo G, Paul P, Gurewich V, Sampol J, Dignat-George F.
    Thromb Haemost; 2006 Apr 01; 95(4):678-88. PubMed ID: 16601839
    [Abstract] [Full Text] [Related]

  • 29. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.
    van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ.
    Blood; 1988 Nov 01; 72(5):1467-73. PubMed ID: 3140909
    [Abstract] [Full Text] [Related]

  • 30. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
    Shetty S, Kumar A, Johnson AR, Pueblitz S, Holiday D, Raghu G, Idell S.
    Am J Respir Cell Mol Biol; 1996 Jul 01; 15(1):78-87. PubMed ID: 8679225
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Effects of urokinase type plasminogen activator and plasminogen activator inhibitor-1 expressions on the formation of aneurysm of perimembranous ventricular septal defect].
    Qian J, Li B, Yin M, Shen P, Sun K.
    Zhonghua Er Ke Za Zhi; 2015 Jun 01; 53(6):453-8. PubMed ID: 26310557
    [Abstract] [Full Text] [Related]

  • 35. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 36. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y, Okada M, Noro A, Matsuda M.
    J Biol Chem; 1988 Feb 05; 263(4):1960-9. PubMed ID: 3123483
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.
    Dodge GR, Diaz A, Sanz-Rodriguez C, Reginato AM, Jimenez SA.
    Arthritis Rheum; 1998 Feb 05; 41(2):274-83. PubMed ID: 9485085
    [Abstract] [Full Text] [Related]

  • 39. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
    Seiffert D, Mimuro J, Schleef RR, Loskutoff DJ.
    Cell Differ Dev; 1990 Dec 02; 32(3):287-92. PubMed ID: 1711915
    [Abstract] [Full Text] [Related]

  • 40. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
    Iwamoto J, Takahashi K, Mizokami Y, Otsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokoube K, Matsuoka T.
    Dig Dis Sci; 2003 Dec 02; 48(12):2247-56. PubMed ID: 14714609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.